Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Pharmacology services11.18M93.05%
Other Translational Oncology Solutions (TOS) revenue835K6.95%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States53.87M100.00%
